Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 6 | 2023 | 114 | 1.920 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2018 | 1054 | 1.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 4 | 2018 | 1088 | 0.840 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2021 | 173 | 0.720 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 294 | 0.620 |
Why?
|
| Granuloma | 2 | 2016 | 159 | 0.590 |
Why?
|
| Interleukin-17 | 1 | 2018 | 257 | 0.550 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 88 | 0.550 |
Why?
|
| Anti-Infective Agents | 2 | 2016 | 465 | 0.490 |
Why?
|
| Trialkyltin Compounds | 1 | 2013 | 3 | 0.460 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2015 | 219 | 0.460 |
Why?
|
| Organotin Compounds | 1 | 2013 | 8 | 0.460 |
Why?
|
| Up-Regulation | 2 | 2018 | 2465 | 0.430 |
Why?
|
| Fibroblasts | 4 | 2024 | 1669 | 0.410 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1146 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2022 | 2093 | 0.390 |
Why?
|
| Killer Cells, Natural | 2 | 2014 | 958 | 0.380 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2021 | 1571 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 687 | 0.360 |
Why?
|
| Bleomycin | 4 | 2024 | 470 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 4182 | 0.280 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1409 | 0.270 |
Why?
|
| Sarcoidosis, Pulmonary | 2 | 2017 | 20 | 0.270 |
Why?
|
| Syndecan-2 | 2 | 2022 | 15 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 350 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2021 | 12207 | 0.210 |
Why?
|
| Lung | 4 | 2024 | 3268 | 0.200 |
Why?
|
| Fibrosis | 1 | 2024 | 746 | 0.190 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 172 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 145 | 0.180 |
Why?
|
| Demography | 2 | 2017 | 435 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2018 | 7295 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2018 | 191 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2018 | 163 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 455 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2017 | 260 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 1654 | 0.130 |
Why?
|
| Polybrominated Biphenyls | 1 | 2014 | 5 | 0.120 |
Why?
|
| Flame Retardants | 1 | 2014 | 5 | 0.120 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2014 | 13 | 0.120 |
Why?
|
| Antimalarials | 1 | 2015 | 54 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2013 | 19 | 0.110 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 311 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2013 | 85 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2017 | 6027 | 0.100 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 2 | 2022 | 16 | 0.100 |
Why?
|
| Mice | 6 | 2024 | 35996 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 388 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 567 | 0.090 |
Why?
|
| Ubiquitination | 2 | 2023 | 577 | 0.090 |
Why?
|
| Humans | 14 | 2024 | 271076 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 1618 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7464 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2014 | 4986 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 5112 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 1426 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2018 | 6492 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 203 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 62871 | 0.070 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 1057 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2024 | 1837 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 5989 | 0.070 |
Why?
|
| Aged | 5 | 2018 | 73177 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2399 | 0.070 |
Why?
|
| Adult | 5 | 2018 | 81614 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 1725 | 0.060 |
Why?
|
| Middle Aged | 5 | 2018 | 90070 | 0.060 |
Why?
|
| Male | 7 | 2023 | 128555 | 0.060 |
Why?
|
| Young Adult | 3 | 2017 | 22062 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 69 | 0.060 |
Why?
|
| Scleroderma, Systemic | 1 | 2024 | 161 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 204 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 5838 | 0.050 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.050 |
Why?
|
| Citrullination | 1 | 2022 | 7 | 0.050 |
Why?
|
| Female | 6 | 2018 | 148608 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2022 | 193 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 347 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 815 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2023 | 1184 | 0.040 |
Why?
|
| Skin | 1 | 2024 | 1290 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 1757 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 2017 | 12 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2021 | 744 | 0.040 |
Why?
|
| Pyridines | 1 | 2024 | 1312 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 184 | 0.040 |
Why?
|
| Mycobacterium | 1 | 2016 | 60 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2021 | 1330 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 920 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 22 | 0.030 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 126 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2021 | 1583 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 146 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 1062 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 604 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 162 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 280 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 4370 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 188 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 4191 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 301 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 1735 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1212 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2024 | 3667 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 837 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 6465 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5784 | 0.020 |
Why?
|
| Cytokines | 1 | 2017 | 2836 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3082 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6896 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 7816 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 7852 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 5107 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 32595 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 11758 | 0.010 |
Why?
|